Treatment regimens for administration of anti‐vascular endothelial growth factor agents for neovascular age‐related macular degeneration New
Treatment regimens for administration of anti‐vascular endothelial growth factor agents for neovascular age‐related macular degeneration New is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Treatment Regimens for Administration of Anti‐vascular Endothelial Growth Factor Agents for Neovascular Age‐related Macular Degeneration New." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439536/all/Treatment_regimens_for_administration_of_anti‐vascular_endothelial_growth_factor_agents_for_neovascular_age‐related_macular_degeneration_New. Accessed 27 February 2021.
Treatment regimens for administration of anti‐vascular endothelial growth factor agents for neovascular age‐related macular degeneration New. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439536/all/Treatment_regimens_for_administration_of_anti‐vascular_endothelial_growth_factor_agents_for_neovascular_age‐related_macular_degeneration_New. Accessed February 27, 2021.
Treatment regimens for administration of anti‐vascular endothelial growth factor agents for neovascular age‐related macular degeneration New. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/439536/all/Treatment_regimens_for_administration_of_anti‐vascular_endothelial_growth_factor_agents_for_neovascular_age‐related_macular_degeneration_New
Treatment Regimens for Administration of Anti‐vascular Endothelial Growth Factor Agents for Neovascular Age‐related Macular Degeneration New [Internet]. In: Cochrane Abstracts. [cited 2021 February 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439536/all/Treatment_regimens_for_administration_of_anti‐vascular_endothelial_growth_factor_agents_for_neovascular_age‐related_macular_degeneration_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Treatment regimens for administration of anti‐vascular endothelial growth factor agents for neovascular age‐related macular degeneration New
ID - 439536
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439536/all/Treatment_regimens_for_administration_of_anti‐vascular_endothelial_growth_factor_agents_for_neovascular_age‐related_macular_degeneration_New
DB - Evidence Central
DP - Unbound Medicine
ER -